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One of the long-term goals of synthetic biology is to reliably engineer biological systems that perform human-
defined functions. Currently, researchers face several scientific and technical challenges in designing and
building biological systems, one of which is associatedwith our limited ability to access, transmit, and control
molecular information through the design of functional biomolecules exhibiting novel properties. The fields of
RNA biology and nucleic acid engineering, along with the tremendous interdisciplinary growth of synthetic
biology, are fueling advances in the emerging field of RNA programming in living systems. Researchers
are designing functional RNA molecules that exhibit increasingly complex functions and integrating these
molecules into cellular circuits to program higher-level biological functions. The continued integration and
growth of RNA design and synthetic biology presents exciting potential to transform how we interact with
and program biology.298 Chemistry & Biology 16, March 27, 2009 ª2009 Elsevier Ltd Allmolecules can exhibit structural flexibility, which enables them
to dynamically adopt different conformations and thereby exhibit
allosteric properties. RNA is composed of four nucleotide resi-
dues that interact through well-defined hydrogen-bond, base-
stacking, and electrostatic interactions. RNA secondary struc-
ture is dictated by these hydrogen-bond interactions, allowing
the development of folding programs that predict the secondary
structures and associated free energies of RNA molecules
(Mathews, 2006; Zuker, 2003). The energies involved in RNA
folding are contributed to a lesser degree by tertiary structure,
such that the relationship between RNA sequence, structure,
and function is relatively accessible and predictable. These
properties make RNA a powerful design substrate in synthetic
biology.
RNA Parts
In engineering design, a part is a component that can perform a
basic function. RNA parts are genetic components composed of
RNA molecules that are capable of performing basic biological
functions such as gene regulation, directed conformation
change, and ligand binding. RNA parts can be generally grouped
into three categories based on function: sensors, actuators, and
transmitters (Table 1).
RNA Sensors
Sensors are parts that detect signals. RNA sensors detect
diverse signals, such as temperature and molecular ligands,
through various binding events, including hybridization and
tertiary interactions. Thebindingevent encoded in anRNAsensor
is generally transduced to an actionable event. Therefore, RNA
sensors are typically coupled to other RNA parts.
Temperature Sensors. RNA senses temperature through the
temperature-dependent nature of hybridization interactions.
Naturally occurring RNA sequences can adopt conformations
thataresensitive tosmall temperaturechanges (Lai, 2003).Gener-
ally, temperature-sensitive RNA parts exhibit less structuredIntroduction
The engineering of biological systems that process information,
materials, and energy holds great promise for developing solu-
tions to many global challenges, including renewable energy
production, material synthesis, and medical advancement. Our
ability to understand and routinely engineer biological systems
is limited by the tools available to broadly access, transmit, and
control molecular information encoded in the various properties
of biomolecules. Synthetic biology is a rapidly growing interdisci-
plinary field that involves the application of engineering principles
to the design and construction of synthetic biological systems.
Core objectives of modern synthetic biology have focused on
the engineering of complex biological systems (Basu et al.,
2005; Ro et al., 2006) and the development of engineering frame-
works that support the reliable programming of biological
function, including abstraction, standardization, and modularity
(Endy, 2005). Within the context of these objectives, we review
the emerging field of RNA programming in living systems, which
is itself founded on the more mature fields of RNA biology and
in vitro nucleic acid engineering and computing (Joyce, 2007;
Seeman, 2005). Advances in RNA synthetic biology are providing
the foundational tools and knowledge base that will support
broader efforts in encoding cellular information processing and
control operations in synthetic RNA molecules and integrating
these engineered components with biological networks to
program higher-level biological function (Figure 1).
RNA Provides a ProgrammableMolecular Substrate that
Exhibits Diverse Function
Biological functions are encoded within the variety of biomole-
cules present in living organisms. The biological functions of
one class of nucleic acids, RNA, can be grouped into protein-
coding and non-protein-coding functions. Noncoding RNA
exhibits diverse functional properties, including gene-regulatory,
enzymatic, and ligand-binding properties. In addition, RNArights reserved
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haus et al., 2006). Effort has been directed toward engineering
and refinement of RNA temperature sensors through selection/
screening and rational design approaches. RNA temperature
sensor parts have been developed in combination with different
RNA actuator parts to link changes in temperature to gene-regu-
latory events (Neupert et al., 2008; Waldminghaus et al., 2008;
Yoshimatsu and Nagawa, 1989).
Molecular Sensors. RNA generally senses molecular signals
through direct binding interactions with the molecular target.
RNA aptamers are the most common class of RNA sensor parts
capable of binding ligands with high affinities and specificities
(Hermann and Patel, 2000). The flexibility of RNA as a sensor is
highlighted by the diverse ligands against which RNA aptamers
have been generated, including carbohydrates, proteins, and
small molecules (Hermann and Patel, 2000). RNA aptamers are
typically generated de novo using an iterative in vitro selection
strategy or SELEX (SystematicEvolution of Ligands byEXponen-
tial enrichment) (Ellington and Szostak, 1990; Tuerk and Gold,
1990). In addition, RNA can bind nucleic acids through Watson-
Crick base-pairing, enabling the engineering of RNA sensors to
nucleic acid ligands.
RNA Actuators
Actuators are parts that control a process or event. RNA actua-
tors control the activity of other biological molecules, thereby
affecting responses in living systems, and exhibit a variety of
functions such as gene-expression regulation, posttranslational
regulation, and directed localization.
Gene-Expression Actuators. The most predominant class of
RNA actuators are parts that regulate gene expression, where
actuation can occur through different mechanisms, including
transcription, translation, splicing, and stability. These actuators
can exhibit their regulatory effects either in cis, when the part is
embedded within the target transcript, or in trans, when the part
acts on a separate target RNA.
Figure 1. The Integration of RNA Parts and Devices as Information
Processing and Control Components into Engineered Biological
SystemsChemistry & BioTranscription Termination Actuators. In prokaryotes, tran-
scription attenuation is actuated by cis-acting RNA parts called
transcription terminators (Henkin, 2000). Intrinsic terminators
are the most commonly used class of termination parts and
are composed of GC-rich stem loops followed by a series of U
residues. Transcription termination parts are largely taken from
nature and little engineering has been done to refine or enhance
their function. These parts are implemented downstream of
coding regions and their function is relatively insensitive to the
distance from the stop codon. Researchers have implemented
multiple transcription termination parts in series to improve the
activity exhibited from a single part (Shetty et al., 2008).
Translation Initiation Actuators. In prokaryotes, translation is
initiated at a cis-acting RNA part called a ribosome binding site
(RBS) that mediates ribosome loading onto a transcript (Kozak,
1999). RBSes consist of several consensus nucleotides that
hybridize with the 30 end of the 16S rRNA. In contrast, ribosome
loading in eukaryotes is initiated at the 50 end of a transcript
through a 7-methyl guanosine cap that recruits the translation
initiation machinery. While translation initiation typically occurs
through this cap-dependent mechanism, translation can be
initiated internally at a cis-acting RNA part called an internal ribo-
some entry site (IRES) (Hellen and Sarnow, 2001). IRESes range
from short unstructured sequences, which facilitate translation
initiation through hybridization with 18S rRNA, to large structured
elements, which interact with the initiation machinery (Chappell
et al., 2000; Kieft et al., 2002). RNA engineers have generated
synthetic RBS and IRES sequences with varying activities
(Owens et al., 2001; Rackham and Chin, 2005; Zhou et al.,
2003). The activity of a RBS is determined by the number of inter-
actions it forms with the 16S rRNA and its distance upstream of
the start codon (Chen et al., 1994), whereas the activity of an
IRES is less dependent on this distance and can be increased
when linked in multiple copies (Chappell et al., 2000).
Catalytic Actuators. Ribozymes are catalytic RNA parts that
most commonly catalyze the cleavage and/or ligation of RNA
molecules via a trans-esterification reaction involving metal ions
as cofactors (Doudna and Cech, 2002). The hammerhead ribo-
zyme (hhRz) has been extensively utilized as a gene-regulatory
part due to its small size, ease of design, and rapid kinetics. The
hhRz motif contains a conserved 11-nucleotide catalytic core
encompassed by three stems (I, II, III) (Blount and Uhlenbeck,
2005), where interactions between the nucleotides in stem loops
I and II are critical to intracellular activity (Khvorova et al., 2003).
RNA engineers have put significant effort into refining ribo-
zymes for gene-regulatory functions. For example, synthetic
trans-acting hhRzs have been constructed such that the trans-
ribozyme sequence binds the target transcript through targeting
arms to form a catalytically active structure (Vaish et al., 1998).
HhRzs have been implemented to actuate gene expression
through directed cleavage in cis or in trans by targeting various
regions within a transcript. For example, hhRzs inserted within
the 30 untranslated region (UTR) of target transcripts have been
shown to effectively downregulate gene expression in eukary-
otes (Khvorova et al., 2003; Meaux and Van Hoof, 2006).
HhRz-directed cleavage and gene inhibition has also been
shown within the 50 UTR (Yen et al., 2004), although studies
have indicated that implementation in this location in eukaryotes
can result in nonspecific inhibition of expression due to structurallogy 16, March 27, 2009 ª2009 Elsevier Ltd All rights reserved 299
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cells or generated endogenously fromprimarymiRNA transcripts
(pri-miRNAs) (Meister and Tuschl, 2004). Pri-miRNAs are
processed in the nucleus by the RNase III enzyme Drosha to
precursor miRNAs (pre-miRNAs) (Lee et al., 2003), which are
exported to the cytoplasm by Exportin-5 (Lund et al., 2004).
Exogenously introduced dsRNAs and pre-miRNAs are pro-
cessed in the cytoplasmby theRNase III enzymeDicer (Bernstein
et al., 2001). The cleaved RNAs are unwound and loaded into
multiprotein complexes, where these RNA parts hybridize to
target transcripts and direct cleavage or translational repression
based on the degree of complementarity (Hammond et al., 2000;
Hutvagner and Zamore, 2002).
Due to the efficacy and flexibility of RNAi-mediated gene
silencing, RNA engineers have developed various types of
synthetic RNAi substrates (Dykxhoorn et al., 2003). RNAi
substrates can be expressed from RNA polymerase II or III
promotersas siRNAs, short hairpinRNAs (shRNAs), pre-miRNAs,
or pri-miRNAs (Brummelkampet al., 2002;McManus et al., 2002;
Miyagishi and Taira, 2002; Zeng et al., 2002). Although design
rules have been proposed to guide RNAi substrate design
(Reynolds et al., 2004), typically many sequences must be
screened to generate an effective RNAi substrate. Synthetic
RNAi substrates are commonly designed to be fully complemen-
tary to their targets to induce cleavage, which is a more effective
mechanismof gene silencing. Combinatorial targeting ofmultipleeffects (Yim et al., 2000). Trans-acting hhRzs exhibit greater flex-
ibility in targeting both translated and untranslated transcript
regions (Kijima et al., 1998; Morino et al., 2000; Sakamoto
et al., 1996).
Constitutive/Alternative Splicing Actuators. In eukaryotes,
a vast majority of genes consist of exons (protein coding) and
introns (noncoding), in which the former are joined in processes
of constitutive or alternative splicing to produce single ormultiple
protein isoforms, respectively. Cis-acting RNA sequences direct
splicing events through binding components of the spliceosome
or other auxiliary protein factors that mediate spliceosome
assembly (Maniatis and Tasic, 2002). RNA parts that actuate
splicing events include 50 and 30 splice sites, branch point, and
enhancer and silencer sequences. Little effort has been directed
to the engineering, refinement, and utilization of RNA parts that
actuate splicing events, as our understanding of the ‘‘splicing
code’’ is incomplete (Wang and Burge, 2008). However,
researchers have utilized canonical splicing sequences to
mediate splicing (Yoshimatsu and Nagawa, 1989) and generated
enhancer and silencer sequences that can potentially be used as
refined parts for regulating splicing patterns (Wang et al., 2004).
RNA Interference-Based Actuators. RNA interference (RNAi)
substrates, such as small interfering RNAs (siRNAs) and micro-
RNAs (miRNAs), are gene-regulatory parts that silence gene
expression through the RNAi pathway (Meister and Tuschl,
2004). RNAi-mediated gene silencing is triggered by double-l rights reserved
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gene silencing, detect cellular state, and implement more
complex regulatory schemes (Brown et al., 2007; Rinaudo
et al., 2007).
Antisense-Based Actuators. Antisense RNAs are single-
stranded RNA parts that control the function of their target
RNAs through a hybridization event (Green et al., 1986). Natural
antisense RNAs have been characterized that actuate through
a variety of mechanisms, including cleavage of antisense-target
hybrids by dsRNA-cleaving enzymes and steric inhibition of
gene expression machinery by the bound antisense (Crooke,
2004). Due to the simplicity of their design and gene-regulation
potency, significant effort has been directed to the engineering
and refinement of antisense RNA parts. Trans-acting antisense
RNAs vary in length (20–700 nucleotides) and have been engi-
neered to inhibit the expression of different target genes in
various cellular systems (Bonoli et al., 2006; Bunch and Gold-
stein, 1989; Coleman et al., 1984). Alternatively, cis-acting anti-
sense parts can be implemented to inhibit the function of other
RNA parts. For example, an antisense part can be implemented
in cis to hybridize to a terminator part to form an antiterminator
that inhibits transcription termination (Henkin and Yanofsky,
2002). Cis-acting antisense parts are typically located within
close proximity to their targets and are of sufficient length to
disrupt target function (10–20 nucleotides).
RNase Activity Actuators. RNases are RNA processing
enzymes that act on cellular RNAs through endoribonucleolytic
or exoribonucleolytic activities (Alifano et al., 1994). Specific
RNA parts are recognized and processed by cellular RNases.
For example, Rnt1p, an RNase III enzyme inSaccharomyces cer-
evisiae, cleaves hairpins with conserved tetraloops (Chanfreau
et al., 2000). As another example, RNase E is an Escherichia
coli endoribonuclease that cleaves single-stranded AU-rich
sequences (McDowall et al., 1994). Substrates for both RNases
have been discovered in cellular transcripts, highlighting their
functional roles in processing and degrading mRNA (Ge et al.,
2005; Lundberg et al., 1990). Significant effort has been directed
toward the engineering, refinement, and utilization of cis-acting
RNA parts that actuate RNase activities to regulate gene expres-
sion. The length and location of such RNA parts will depend on
the associated RNase and its intended gene-regulatory function.
For example, stabilizing hairpin parts have been placed at the
50 and 30 ends of transcripts to inhibit RNase E and exoribonu-
clease activities, respectively (Carrier and Keasling, 1997).
RNase activity actuation parts exhibiting varying activities have
been generated through sequence and structural modification
(Carrier and Keasling, 1999; Smolke et al., 2000).
Aptamer-Based Translational Actuators. In addition to acting
as sensors, RNA aptamers can function as cis-acting gene-regu-
latory parts. RNA aptamer-based translational actuators respon-
sive to various small molecules have been embedded within the
50 UTR of target eukaryotic transcripts (Harvey et al., 2002;
Suess et al., 2003; Werstuck and Green, 1998). The aptamer
sequence adopts a more structured conformation upon binding
its ligand that inhibits ribosomal scanning, thereby reducing
expression levels in a ligand-dependent manner. However, the
general relationship between the relative location of the aptamer
within the 50 UTR and translational efficacy remains unclear, as
other studies have indicated that secondary structures withinChemistry & Biothis region inhibit translation (Pelletier and Sonenberg, 1985). It
is possible that the ability of RNA aptamers to function as
gene-regulatory parts is dependent on specific properties of the
aptamer and its location relative to other RNA parts in the tran-
script. RNA aptamer-based translational actuators encode two
functions, sensing and actuation, and are therefore an example
of a double-coding part.
Posttranslational Activity Actuators. A second class of RNA
actuators functions to regulate the activity of biological mole-
cules. RNA aptamers can function as trans-acting RNA parts
that actuate the activity of molecules posttranslationally through
binding interactions. Binding of a synthetic RNA aptamer to its
molecular ligand can interact with chemical moieties important
to the functional activity of the ligand, resulting in inhibition
(Famulok et al., 2001) or enhancement of activity (Babendure
et al., 2003). RNA-based posttranslational activity actuators are
another example of a double-coding part. Intramers are a class
of RNA aptamer-based posttranslational activity actuators that
are expressed intracellularly to inhibit the activity of various
molecular ligands (Famulok et al., 2001). For example, intramers
against viral proteins (Kim and Jeong, 2004; Nishikawa et al.,
2003) have been shown to inhibit the activities of the target viral
proteins in human cells, thereby reducing or inhibiting viral
infectivity.
Localization Actuators. A third class of RNA actuators functions
todirect localizationofbiologicalmolecules todifferentmolecules,
cellular compartments, or specific cells. Localization of mRNA is
used to achieve higher local protein concentrations (Hazelrigg,
1998), whereas localization of gene-regulatory RNAs and tran-
scripts can be used to achieve conditional or enhanced control
of gene-regulatory functions (Lee et al., 1999). Sequences that
bind protein factors responsible for localization effects, termed
zip codes, can be used as cis-acting localization parts (Bassell
et al., 1999). Localization strategies can also be performed by
scaffold parts that bring molecular targets close together to
enhance function associated with their interactions. Although
such scaffolding functions are typically performed by proteins in
nature (Pawson andScott, 1997), the ability of RNA tobindmolec-
ular ligands supports its potential use as a scaffold part.
RNA localization parts have either been adapted from nature
or generated as RNA aptamers to specific molecular targets.
For example, heterologous transcripts harboring RNA zip-code
parts within their 30 UTRs have been localized to targeted
compartments within the cytoplasm (Kislauskis et al., 1993). In
addition, such RNA zip-code parts have been integrated with
other RNA actuation parts to enhance gene-regulatory activities
through colocalization. For example, the human a- and b-actin
zip codes were engineered into trans-acting hhRzs and target
genes, and the constructs harboring matched zip codes (a-a,
b-b) exhibited enhanced colocalization and ribozyme-mediated
inhibition of target expression (Lee et al., 1999). As another
example, synthetic RNA scaffolds have been built linking
multiple RNA aptamers to localize DNA-binding and transcrip-
tional activation proteins to allow transcription initiation in yeast
(Cassiday and Maher, 2001).
RNA Transmitters
Transmitters are parts that send or convert signals between
different components. RNA transmitters are RNA sequences
that translate an informational event (such as signal detectionlogy 16, March 27, 2009 ª2009 Elsevier Ltd All rights reserved 301
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tional changes, and thus are typically coupled to other RNA
parts.
Communication Module Parts. Communication module parts
are based on a single sequence that can bind to a partially
complementary target strand in more than one way, where the
energetics of strand binding allow the part to move between
different bound states through a helix-slipping event (Soukup
and Breaker, 1999).
Strand Displacement Parts. Strand displacement parts are
based on two sequences that compete for binding to a comple-
mentary target strand, where the energetics of each binding
event allow the part to move between different bound states
through a competitive hybridization event (Mandal and Breaker,
2004).
RNA Devices
A device in engineering design is a combination of refined parts
that can perform a human-defined function (Endy, 2005). RNA
devices are composed of more than one functionally distinct
RNA parts and are capable of performing programmed
biological functions. Riboswitches are naturally occurring coun-
terparts of RNA devices that link molecular sensing and gene-
regulatory functions (Mandal and Breaker, 2004). Riboswitches
control gene expression in response to specific molecular inputs
and act through diverse gene expression mechanisms (Breaker,
2008). Although the majority of riboswitches respond to cellular
metabolites, riboswitches that incorporate temperature sensors
have also been characterized (Narberhaus et al., 2006). Ribos-
witches that incorporate multiple sensor and actuator domains
through more complex architectures to perform higher-order
regulatory functions, such as cooperativity andmulti-input signal
integration, have also been identified (Breaker, 2008).
Building on these natural examples, engineers have built
a variety of RNA devices that process and transmit molecular
inputs to targeted gene expression outputs in different cellular
systems (Isaacs et al., 2006; Suess and Weigand, 2008). Engi-
neers have adopted various design strategies to build RNA
devices from combinations of diverse parts and have
employed both screening/selection and rational design
approaches.
RNA Devices Based on the Direct Coupling
of Sensor and Actuator Parts
A direct coupling device design strategy is one that links the
sensor and actuator parts directly without the inclusion of
a distinct transmitter part (Figure 2A). In this strategy, information
(in the form of input binding to the sensor) is typically transmitted
between the two parts through conformational changes associ-
ated with ligand binding to the aptamer that are specific to each
aptamer-ligand pair. As a result, the coupling of parts into a
Figure 2. RNA Device Design Strategies
(A) A device design strategy based on the direct coupling of sensor and actu-
ator parts.
(B) A device design strategy based on the integration of a transmitter part
between the sensor and actuator parts.
(C) A device design strategy based on the integration of a transmitter part that
enables the modular assembly of sensor, actuator, and transmitter parts.rights reserved
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mechanistic properties of the sensor and actuator.
Early examples of the direct coupling strategy were imple-
mented based on the replacement of a portion of the actuator
with the sensor. For example, a ribozyme-based RNA device
was built by replacing a stem in the group I self-splicing intron
from the bacteriophage T4 thymidylate synthase gene with the
theophylline aptamer (Thompson et al., 2002). The device was
integrated into its native gene and demonstrated theophylline-
dependent splicing and regulation of cell growth in an E. coli
thymidine auxotroph strain. In another example (Buskirk et al.,
2004), an input-dependent transcriptional activator activity was
built by replacing a stem in a RNA part that functions as a
transcriptional activator (Buskirk et al., 2003) with the tetrame-
thylrosamine (TMR) aptamer (Grate and Wilson, 1999). A func-
tional TMR-responsive device was generated by randomizing
several nucleotides in the region connecting the two parts and
selecting for TMR-responsive sequences, which allowed the
conformational change associated with TMR binding to activate
the transcriptional activator.
Other examples are based on the direct coupling of the sensor
and actuator sequences. In one example, the theophylline
aptamer was directly coupled to a shRNA actuator (An et al.,
2006) (Figure 2A). Dicer cleavage of the shRNA sequence was
inhibited by theophylline, resulting in small molecule regulation
of RNAi-based gene silencing. The device function was shown
to be very sensitive to the distance between the Dicer cleavage
site and ligand binding site, because changes of even one base
pair abolished function. RNA devices have also been shown to
effectively regulate splicing and alternative splicing through this
strategy by coupling small molecule aptamers to 50 splice site
and branch point sequences (Kim et al., 2008; Weigand and
Suess, 2007).
RNA Devices Based on Integration of a Distinct
Information Transmission Function
A second type of device design strategy is one that links the
sensor and actuator parts through a separate transmitter part
(Figure 2B). The transmitter part typically translates information
between the sensor and actuator through a change in secondary
structure. In this way information is transmitted through a mech-
anism that is itself independent of input binding to the sensor,
such that the molecule adopts at least two different conforma-
tions associated with an active or inactive sensor. Input binding
to the conformation harboring an active sensor shifts the distri-
bution between these conformations to favor the input-bound
state. By introducing an information transmission function that
is distinct from the input binding event, devices can achieve
greater flexibility in the coupling of actuator and sensor parts.
Several examples of RNA devices that link aptamers to trans-
lation initiation parts through linker sequences that perform
information transmission functions have been described. The
actuator of these devices is regulated by modulating its accessi-
bility to translationalmachinery throughhybridization interactions
with the actuator sequence. For example, RBS-based devices
were developed by coupling the theophylline aptamer to a RBS
through a randomized linker region (Figure 2B). The linker region
was varied in length and theophylline-responsive devices were
screened through colorimetric, flow cytometry, and cell motility
assays in E. coli by altering the gene regulatory output (DesaiChemistry & BioandGallivan, 2004; Lynch andGallivan, 2009; Topp andGallivan,
2008). The devices function through modulating ribosomal
accessibility to the RBS via a strand displacement mechanism,
where the RBS was partially base-paired with the aptamer in
a gene OFF state or released from base-pairing in the gene ON
state in the input-bound conformation. The aptamer sequence
in this device design strategy encodes for both ligand binding
and antisense functions such that the sequences of the sensor
and actuator are not independent of one another and cannot be
independently modified while maintaining device function. A
similar RBS-based device was built through the coupling of the
theophylline aptamer to a RBS through a helix slipping-based
transmitter part, or communication module (Suess et al., 2004),
where small nucleotide shifts led to changes in the accessibility
of theRBSandactive state of the aptamer. Similar selection strat-
egies have been applied to generate RBS-based devices that
exhibit logic operations (AND, NAND) by coupling the theophyl-
line aptamer to a natural riboswitch element through a random-
ized linker region (Sharma et al., 2008).
Other examples of RNA devices built with separate transmitter
parts couplemultiple actuators into a single device. For example,
two recent RBS-based devices were designed to regulate ribo-
some access to the RBS through ribozyme cleavage (Ogawa
and Maeda, 2008; Wieland and Hartig, 2008). The RBS and
hhRz actuators were coupled such that the RBS was seques-
tered within the ribozyme structure and cleavage of the ribozyme
resulted in separation of the two parts, thereby increasing
ribosome access and expression levels. Ribozyme cleavage
was in turn modulated by binding of theophylline to its aptamer,
which was linked through a communication module to the ribo-
zyme. In another example, a RBS-based device was designed
to regulate ribosome access to the RBS through cis- and trans-
acting antisense parts (Isaacs et al., 2004). A cis-acting antisense
was implemented to inhibit ribosome access to a RBS and
a trans-acting antisense was employed to activate expression
by hybridizing with the cis-acting antisense. Although this device
design offers a greater level of flexibility in tailoring parts due to
the isolation of binding events to hybridization interactions, the
sequence of the cis-acting antisense is dependent on both the
RBS and the trans-acting antisense, thereby rendering interde-
pendence among the parts.
Functional Composition Frameworks in Device Design
that Support Modular Assembly Strategies
One of the goals of synthetic biology is to develop foundational
technologies that make the engineering of biology easier and
more reliable (Endy, 2005). Efforts are being directed to the
development of functional composition frameworks, which are
a type of device design strategy that supports the construction
of devices through modular assembly of distinct parts and are
therefore characterized by functional modularity. In engineering
design, such frameworks support the efficient and reliable engi-
neering of diverse device functions from a smaller number of
refined parts through a plug-and-play type strategy without
complex device redesign.
Functional composition frameworks have recently been
proposed for single-input single-output RNA device design. In
the proposed design strategies functional modularity is achieved
through the separation of functions (sensing, actuation, informa-
tion transmission) into distinct and independent parts (Figure 3A).logy 16, March 27, 2009 ª2009 Elsevier Ltd All rights reserved 303
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transmission function in a distinct transmitter part that employs
a strand displacement event solely with the sequences of that
part, such that the sequences of the sensor and actuator do
not depend on one another and can be changed independently.
Therefore, the integration of sensor-actuation functions is simpli-
fied via a distinct transmitter part that insulates part functions
and controls the interactions between parts through predictive
hybridization interactions.
In one example, a functional composition framework for RNA
device design was proposed based on the assembly of three
parts (Win and Smolke, 2007): a sensor, made of an RNA ap-
tamer; an actuator, made of a self-cleaving hhRz; and a strand
displacement-based transmitter part (Figure 2C). Several design
strategies were employed in the implementation of this device
platform to support engineering properties such as portability,
utility, and composability. For example, the RNA device was
integrated into the 30 UTR of the target transcript, which is a flex-
ible and extensible sequence space where the integration of
RNA devices is anticipated to have minimal nonspecific effects
on expression. In addition, ribozyme self-cleavage in the 30
UTR inactivates a transcript and thereby lowers gene expression
independent of cell-specific machinery, thus enabling portability
across organisms. Flanking sequences were also included to
Figure 3. A Functional Composition
Framework that Supports Modular
Assembly of Single-Input Single-Output
RNA Devices and Extension to Higher-
Order Devices
(A) The flow of information through the modular
parts of an RNA device.
(B)Modular assembly of single-input single-output
RNA devices that exhibit different information
processing functions.
(C) Extension to the modular assembly of RNA
devices that exhibit higher-order information
processing functions.
insulate the device from surrounding
sequences that might disrupt its structure
and therefore activity to support reliable
coupling to other parts and devices.
Ribozyme-based devices were built in
which the input-bound conformation
was associated with the disruption or
restoration of the ribozyme catalytic
core and thus converted a molecular
input to increased (ON switch) or
decreased (OFF switch) expression,
respectively, based on the transmitter
part (Figure 3B). The device response
properties were programmed by altering
sequences within the transmitter part,
which alters the energetic and kinetic
properties of the strand displacement
event and therefore the ability of the
device to access the different conforma-
tional states. The functional modularity
of the framework was shown to support
direct sensor replacement strategies, such that aptamer
sequences to different molecular inputs (theophylline and tetra-
cycline) were swapped into the framework and the function of
the device was maintained while being made responsive to
a new input (Figure 3B).
A similar framework was used to build RNA devices that
actuate through the RNAi pathway by coupling an aptamer to
a shRNA through a distinct strand displacement-based trans-
mitter part (Beisel et al., 2008). shRNA-based devices were built
in which the input-bound conformation was associated with the
disruption of the shRNA stem, thereby inhibitingDicer processing
and subsequent gene silencing, converting a molecular input to
increased (ON switch) expression of reporter and endogenous
gene targets. The functional modularity of both the sensor and
actuator parts in this framework was further highlighted in this
example.
Composition Frameworks that Support Extensions
to Higher-Order Device Functions
One of the important properties of a composition framework is its
extensibility to the assembly of more complex devices that
enable sophisticated programmed information processing and
control functions from basic sensing, actuation, and information
transmission parts. Such frameworks will provide general ap-
proaches for the forward engineering of multi-input, higher-order304 Chemistry & Biology 16, March 27, 2009 ª2009 Elsevier Ltd All rights reserved
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formation processing, transduction, and control devices from a
smaller number of refined parts.
Recent work has described the extension of the functional
composition framework described above for single-input
single-output ribozyme-based devices to the modular assembly
of devices that perform higher-order functions from a small set of
refined sensor, actuator, and transmitter parts (Win and Smolke,
2008) (Figure 3C). Three signal integration schemes based on
single layer device architectures were developed that involve
the assembly of multiple single-input single-output RNA devices
and the coupling of multiple sensor-transmitter components to
single ribozyme actuators. RNA devices that function as logic
gates (AND, NOR, NAND, OR gates), signal and bandpass filters,
and cooperative control devices were built on the extended
framework.
RNA Device Performance Characterization
and Measurement Standards
In support of the reuse of refined components and their efficient
integration into engineered biological systems, synthetic biolo-
gists are fueling discussions on technical standards in part and
device characterization (Canton et al., 2008). Different metrics
have been used to report the performance of RNA parts and
devices to date, making performance comparisons and the
downstream integration of these components into different
application-specific systems challenging.
The properties that characterize the performance of a RNA
device based on gene expression actuation include baseline
expression (Sd,0, expression activity in the absence of input),
input response range (input concentration over which device
output changes), and output dynamic range (reported as either
a difference, Sd,L-Sd,0, or ratio, Sd,L/Sd,0, of the expression
activity in the presence and absence of input) (Figure 4). Gener-
ally, these performance descriptors cannot be compared across
different genetic systems, such that reporting properties relative
to standards is critical to enabling device comparison. The use of
Figure 4. RNA Device Performance CharacterizationChemistry & Biotwo standards in RNA device characterization was recently
proposed (Win and Smolke, 2008): (i) the gene expression
activity from the genetic construct in the absence of the RNA
device (100%; signal standard, SS); and (ii) the gene expression
activity in the absence of the genetic construct (0%; background
standard, SB). These proposed standards determine the RNA
device performance across the full transcriptional range of a
specified promoter, without any nonspecific effects that a device
might exhibit due to its location relative to other components in
the construct.
With the goal of integrating RNA devices into genetic circuits
composed of diverse biological components, such standardized
characterization information is critical to match component
properties to achieve the desired system response. For
example, proteins can exhibit very different thresholds of titrat-
able function depending on their activities and the properties
of the other components comprising the genetic circuit. Such
system properties will guide the design of the RNA device
properties to match those of the components in the circuit by
optimizing for different design criteria. The demonstrated ability
to tune RNA device response to fit performance requirements of
specific applications using (1) energetic tuning strategies (Beisel
et al., 2008; Win and Smolke, 2007); (2) higher-order architec-
tures (Win and Smolke, 2008); and (3) component matching
strategies (Yokobayashi et al., 2002) is a critical property for their
utility in downstream applications.
Enabling Technologies that Support the Engineering
of RNA Devices
The engineering of RNA devices requires the integration of several
enabling technologies (Figure 5). As a basic enabling technology,
strategies that support high-throughput and reliable RNA part
generation, refinement, and characterization are critical to RNA
deviceengineering.Generally,RNAgene-actuator parts areadap-
ted from nature with little modification or designed from relatively
simple hybridization-based design rules, although somework has
focused on the in vitro evolution of RNA actuators exhibiting
enhanced function (Conaty et al., 1999; Vaish et al., 1997). RNA
sensorparts havebeenadapted fromnaturallyoccurringelements
(Nomura and Yokobayashi, 2007), but are more often generated
through in vitro selection strategies. The generation of RNA ap-
tamers exhibiting desired in vivo affinities and specificities is
currently a limiting step in device design. In vitro selection strate-
gies for DNA aptamers to proteins have been adapted to high-
throughput formats (Cox et al., 2002) and higher efficiency parti-
tioning schemes such as capillary electrophoresis (Berezovski
et al., 2005; Drabovich et al., 2005). However, improved aptamer
generation schemes have not yet been demonstrated for RNA
aptamers and other groups of targets such as small molecules.
Composition frameworks that support the rapid assembly of
RNA devices from parts exhibiting more basic functions are
another enabling technology in support of more efficient and
reliable device design. Although first-generation frameworks
have recently been demonstrated that highlight the design
advantages afforded through such engineering design principles
(Beisel et al., 2008; Win and Smolke, 2007; Win and Smolke,
2008), much work remains in optimizing and refining RNA device
frameworks. For example, effective composition frameworks
require the careful refinement of parts such that the parts arelogy 16, March 27, 2009 ª2009 Elsevier Ltd All rights reserved 305
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libraries of well-characterized, refined RNA parts that are
compatible with device frameworks are needed to support this
enabling technology. In addition, frameworks that address exist-
ing challenges in enhancing functional device performance (Bei-
sel et al., 2008; Win and Smolke, 2007), such as dynamic range
and insulation of part functions are needed. Such improved
frameworks will likely require the integration of new technologies
that allow the measurement of RNA folding and switching rates
(Greenleaf et al., 2008), thereby advancing our understanding
of RNA structure-function relationships. Finally, extended archi-
tectures (Deans et al., 2007; Rinaudo et al., 2007; Win and
Smolke, 2008), including single-layered and multilayered
systems composed of heterogeneous components, are impor-
tant to support the engineering of more complex device
functions such as signal restoration and amplification.
Strategies that support the engineering of parts within an RNA
device platform can increase the efficiency of new device
construction by removing the additional step of part integration
and functional optimization. For example, transmitter parts have
been generated by applying in vitro (Soukup and Breaker, 1999)
and in vivo screening strategies to small libraries within func-
tional device platforms (Lynch et al., 2007; Wieland and Hartig,
2008; Win and Smolke, 2007). The latter strategy benefits from
selecting for function within the desired cellular context, as parts
that have been generated in vitro do not necessarily translate to
functional elements within the cellular environment (Link et al.,
2007; Win and Smolke, 2007). More recently, cell-based
screening strategies for transmitter parts have been adapted to
higher-throughput methods based on fluorescence activated
cell sorting (FACS) (Fowler et al., 2008; Lynch and Gallivan,
2009). Researchers have also demonstrated the application of
such higher-throughput screening methods to RNA gene-actua-
tion parts in the device platform by extending the randomized
region into the actuator (Lynch and Gallivan, 2009). An important
area of future research will be to direct such high-throughput,
cell-based screening strategies to the generation of new sensor
parts within device platforms.
Figure 5. Process Flow of Enabling
Technologies Supporting Device Design
and Implementation into Engineered
Systems
Finally, computational tools that
support the in silico design and program-
ming of device function will provide a crit-
ical enabling technology to matching
quantitative device response properties
to application-specific performance
requirements. Recent modeling tools
have been described that provide early
sequence-to-function computational
frameworks for guiding and optimizing
RNA device design (Beisel et al., 2008).
The refinement of such in silico device
design tools will require further insight
into RNA structure-function relationships
(Martick and Scott, 2006), kinetic and
thermodynamic properties of RNA folding (Greenleaf et al.,
2008), and improved predictions of RNA secondary and tertiary
structures (Parisien and Major, 2008).
The Implementation of RNA Parts and Devices
in Engineered Systems
Within living systems, RNA parts and devices are integrated into
genetic circuits composed of heterogeneous parts, including
proteins and small molecules, which comprise devices and
systems exhibiting human-defined functions. Numerous exam-
ples of the integration of RNA parts into heterogeneous systems
have been described, and more recent examples have focused
on the integration of RNA devices into circuits encoding func-
tions relevant for biotechnological or medical applications,
including metabolic engineering, cellular biosensing, phenotype
generation, and therapeutics.
In the rapidly growing field ofmetabolic engineering, RNAparts
have been implemented as tools to tune enzyme levels, regulate
pathway flux, and optimize product yields. In one example,
RNase activity actuators were integrated in intergenic regions
of a polycistronic transcript to direct its segmental processing
and stability, resulting in differential expression of multiple target
genes in E. coli (Smolke et al., 2000). This engineering strategy
was applied to control the flux through a synthetic carotenoid
pathway, where accumulation levels of the intermediate pathway
metabolites were varied through implementation of RNase
activity actuators exhibiting different regulatory strengths
(Smolke et al., 2001). A modified strategy was developed based
on the generation of libraries of combinations of RNase activity
actuators that were screened through FACS for combinations
that resulted in desired expression ratios (Pfleger et al., 2006).
This strategy was applied to a synthetic mevalonate pathway
using a biosensor assay to screen for mevalonate production
to optimize the relative expression of three pathway enzymes,
resulting in a 7-fold increase in mevalonate levels.
RNA parts have also been implemented as regulatory compo-
nents in circuits that have potential application in gene therapy.
In a recent example, RNAi-based actuators were integrated as306 Chemistry & Biology 16, March 27, 2009 ª2009 Elsevier Ltd All rights reserved
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a tight and tunable transgenic regulatory system (Deans et al.,
2007). The gene circuit coupled heterogeneous actuator parts,
repressor proteins and shRNAs, to significantly reduce the basal
expression of the regulated gene from any single actuator. The
response of the genetic circuit was shown to be tunable and
applied to the small-molecule-responsive regulation of mamma-
lian cell growth.
Recent work has also demonstrated the implementation of
RNA devices in genetic circuits that are relevant to biotechnolog-
ical applications. For example, the application of RNA devices to
the noninvasive detection of intracellular metabolite levels was
recently demonstrated (Win and Smolke, 2007). Ribozyme-
based devices were implemented as in vivo biosensors for the
detection of xanthine accumulation in S. cerevisiae by transmit-
ting the metabolite binding event to a change in fluorescent
protein levels. Genetic circuits that integrate RNA devices
toward the regulation of cellular phenotypes and traits have
also been demonstrated. In one example, an RNA device was
integrated into a genetic circuit in E. coli that enabled cells to
detect, follow, and precisely locate a molecular signal (Topp
and Gallivan, 2007). The genetic circuit implemented a theophyl-
line-responsive RBS-based device for the regulation of the cheZ
gene encoding a chemotaxis protein responsible for cell motility.
RNA devices have also been implemented in potential thera-
peutic applications. In one example, an RNA device composed
of aptamer and antisense parts that interact in trans through
hybridization was applied as a controlled therapeutic agent
(Rusconi et al., 2002). The device implemented an aptamer to
coagulant factor IXa as an antagonist and an antisense RNA as
an antidote to the function encoded in the aptamer. The ap-
tamer-antisense device was shown to function as a potent anti-
coagulant drug and antidote combination in plasma and animal
models (Rusconi et al., 2004). In another example, anRNAdevice
combining zip-code andgene-regulatory partswas implemented
for targeted delivery of gene-actuation parts to silence the
expression of survival genes (McNamara et al., 2006). The device
was composed of an RNA aptamer that binds to the prostate-
specific membrane antigen, which is overexpressed in prostate
cancer cells, and a siRNA that silences a target gene. The device
was demonstrated to trigger targeted gene silencing and
apoptosis in cell culture and animal models.
Conclusion
The thoughtful combination of scientific research and engi-
neering theory has resulted in significant advances in the design
of functional RNA molecules. Importantly, the field of RNA engi-
neering has been fueled, influenced, and inspired by discoveries
andadvances in the areas of RNAbiology and in vitro nucleic acid
engineering. The recent application of synthetic biology princi-
ples has resulted inmore efficient and effective design strategies
supporting the programming of RNA devices that perform
complex information processing, transduction, communication,
and control functions in living systems. The integration of future
scientific and technological advances will lead to enabling tech-
nologies supporting the more reliable and robust programming
of RNA parts and devices and their integration as functional
components into biological networks and systems. The resulting
improvements in our ability to transmit information to and fromChemistry & Bioliving systems, and implement control within cells themselves,
will transform how we interact with and program biology.
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